SCHEMBL86618

SCHEMBL86618

NC(CO)(CO)CCc1ccc(OC/C=C/c2ccc(C(F)(F)F)cc2)c(C(F)(F)F)c1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 5/20 0.57
TNNC1 P63316 1/20 0.43
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
PTGES O14684 1/20 0.36
ALOX5 P09917 1/20 0.36
PPARG P37231 1/20 0.36
PSEN1 P49768 1/20 0.36
PTGS1 P23219 1/20 0.35
MMP1 P03956 1/20 0.35
MAOB P27338 2/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
S1PR5 Q9H228 3/20 0.34
S1PR3 Q99500 2/20 0.34
MAOA P21397 1/20 0.34
CYP1A2 P05177 1/20 0.33
CXCL12 P48061 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL80133 0.99 S1PR1 (0.56) S1PR1TNNC1RXRARXRBRXRG
Hydrochloric Acid SCHEMBL80132 0.99 S1PR1 (0.56) S1PR1TNNC1RXRARXRBRXRG
SCHEMBL86393 0.92 S1PR1 (0.57) S1PR1TNNC1RXRARXRBRXRG
Hydrochloric Acid SCHEMBL79318 0.91 S1PR1 (0.56) S1PR1TNNC1RXRARXRBRXRG
Hydrochloric Acid SCHEMBL79319 0.91 S1PR1 (0.56) S1PR1TNNC1RXRARXRBRXRG
SCHEMBL86450 0.91 S1PR1 (0.56) S1PR1TNNC1RXRARXRBRXRG
SCHEMBL86409 0.91 S1PR1 (0.59) S1PR1TNNC1RXRARXRBRXRG
SCHEMBL86924 0.91 S1PR1 (0.58) S1PR1TNNC1RXRARXRBRXRG
SCHEMBL80541 0.90 S1PR1 (0.47) S1PR1TNNC1RXRARXRBRXRG
SCHEMBL80542 0.90 S1PR1 (0.47) S1PR1TNNC1RXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2168944-B1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2016-05-11 EP disclosed
US-8129361-B2 Amine compound and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-03-06 US disclosed
US-8129361-B2 Amine compound and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-03-06 US disclosed
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-15 US disclosed
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-15 US disclosed
EP-2168944-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2010-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF HLA-B, HLA-A, HLA-C S1PR1 511/4885TNNC1 602/4885RXRA 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.